CANCELLATION OF KEY MEETING RAISES QUESTIONS ABOUT FUTURE SHAPE OF PART 11

Executive Briefing Series
A A

The FDA decision to cancel and not reschedule the CFR 21 Part 11 public meeting slated for June 11 has created consternation among industry officials seeking guidance on the future shape of the agency’s regulations covering electronic records and electronic signatures.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $10.00